Drug-coated balloons (DCBs), also called drug-eluting balloons, are a specialized type of angioplasty balloon used in the treatment of peripheral arterial disease (PAD). Unlike a standard balloon that only mechanically opens a narrowed artery, a DCB is coated with a medication — typically an antiproliferative drug called paclitaxel — that transfers to the artery wall during balloon inflation. The intent is to help reduce the likelihood of the artery renarrowing over time, a process known as restenosis.
What Problem Do Drug-Coated Balloons Address?
After standard balloon angioplasty, some arteries experience restenosis as the vessel wall responds to the mechanical injury of the procedure with cellular growth (neointimal hyperplasia) that can gradually renarrow the treated segment. Drug-coated balloons were developed to address this specific concern by delivering a localized dose of medication designed to inhibit this excess cellular proliferation.
How Does the Drug Transfer Work?
During a DCB procedure, the coated balloon is positioned at the target lesion and inflated, similar to standard angioplasty. As the balloon surface contacts the vessel wall, the drug coating is transferred into the arterial tissue during the inflation period. Because the balloon is later withdrawn from the body, no permanent drug-delivery implant remains in the artery — this is a key distinction from drug-eluting stents, which remain in place.
Devices such as the INVAMED Extender Drug PTA Balloon Catheter are engineered with a paclitaxel-iopromide coating formulated for rapid, uniform drug release into the vessel wall upon inflation, using a coating designed to resist delamination during navigation to the treatment site.
When Might a Physician Choose a Drug-Coated Balloon?
The decision to use a DCB rather than a plain balloon or a stent depends on multiple factors that a physician evaluates individually, including lesion location, length, vessel size, and the patient's overall clinical picture. DCBs are commonly considered for certain femoropopliteal lesions, where reducing the need for a permanent implant across a joint-crossing segment may be a relevant consideration.
What Are the General Steps of a DCB Procedure?
A typical DCB-based procedure generally follows this sequence:
- Diagnostic imaging to characterize the lesion
- Initial vessel preparation, which may include standard balloon angioplasty or atherectomy, particularly for calcified lesions
- Positioning of the drug-coated balloon at the target segment
- Controlled inflation for a set duration to allow drug transfer
- Balloon deflation and withdrawal
- Imaging assessment of the treated segment
What Should Patients Know About DCB Treatment?
As with any endovascular procedure, DCB angioplasty carries risks, and outcomes vary by individual. Physicians consider a patient's full medical history, including any contraindications to antiproliferative medications, before recommending this approach. Patients should discuss the specific rationale, expected process, and any relevant risks with their treating physician.
Frequently Asked Questions
Are drug-coated balloons the same as drug-eluting stents?
No. A drug-coated balloon delivers medication to the vessel wall and is then removed from the body, leaving no permanent implant, while a drug-eluting stent remains permanently in the artery to provide both medication delivery and structural support. The choice between these approaches depends on the specific clinical situation.
Do drug-coated balloons eliminate the risk of restenosis?
No treatment can guarantee that restenosis will not occur. Drug-coated balloons are designed to help reduce the likelihood of restenosis compared to plain balloon angioplasty alone, but individual outcomes vary and long-term follow-up remains important.
What drug is typically used in peripheral drug-coated balloons?
Paclitaxel is the antiproliferative agent most commonly used in peripheral drug-coated balloon technology. Your physician can explain the specific product and coating technology being considered for your treatment.
Related INVAMED Resources
- Extender Drug PTA Balloon Catheter
- Peripheral Arterial Disease (PAD) Products
- Contact INVAMED for More Information
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.